Skip to content

Platelet-rich Plasma Combined with Sodium Hyaluronate Guided by Ultrasound for Partial-thickness Rotator Cuff Tears

Platelet-rich Plasma Combined with Sodium Hyaluronate Guided by Ultrasound for Partial-thickness Rotator Cuff Tears

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013172
Enrollment
Unknown
Registered
2017-10-30
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

partial-thickness rotator cuff tears

Interventions

NS group:NS
SH group:SH
PRP+SH group:PRP+SH

Sponsors

Puai Hospital, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.;Inclusion criteria: Primary, traumatic, or non-traumatic PTRCTs (T-PTRCTs or/and NT- PTRCTs) located in supraspinatus measuring not more than 6 mm according to Ellman's Classification; Symptomatic PTRCTs patients within 6 months of initial diagnosis.

Exclusion criteria

Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.;Exclusion criteria: Rotator cuff tears secondary to fracture; Prior surgical repair or revision arthroscopy; Prior platelet-rich plasma, sodium hyaluronate injection or other drug intervention; Previous history of pregnancy, mental sickness, cardio-cerebrovascular disease, shoulder pain induced by non-RCT; Active infection; Hemoglobin < 7.0 g/dl or platelets < 15,000/µL.

Design outcomes

Primary

MeasureTime frame
ASES score;

Secondary

MeasureTime frame
VAS scroe;MRI;

Countries

China

Contacts

Public ContactZhu pengfei;Zhu pengfei;Zhu pengfei;Zhu pengfei;Zhu pengfei ;;;;

Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology;Puai Hospital, Huazhong University of Science and Technology

happyzhupengfei@163.com;happyzhupengfei@163.com;happyzhupengfei@163.com;happyzhupengfei@163.com;happyzhupengfei@163.com+86 13720162185;+86 13720162185;+86 13720162185;+86 13720162185;+86 13720162185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026